The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Publication Year: 2021

Authors & Co-authors:  Jansen van Vuren Esmé E Steyn Stephan F SF Brink Christiaan B CB Möller Marisa M Viljoen Francois P FP Harvey Brian H BH

An acute dose-ranging evaluation of the antidepressant properties of Sceletium tortuosum (Zembrin®) versus escitalopram in the Flinders Sensitive Line rat.

Journal: Journal of ethnopharmacology

Publication Year: 2022

Authors & Co-authors:  Gericke Johané J Lekhooa Makhotso M Steyn Stephan F SF Viljoen Alvaro M AM Harvey Brian H BH

Reviewing the mitochondrial dysfunction paradigm in rodent models as platforms for neuropsychiatric disease research.

Journal: Mitochondrion

Publication Year: 2022

Authors & Co-authors:  van Rensburg Daniël J DJ Lindeque Zander Z Harvey Brian H BH Steyn Stephan F SF

Use of a gene expression signature to identify trimetazidine for repurposing to treat bipolar depression.

Journal: Bipolar disorders

Publication Year: 2023

Authors & Co-authors:  Bortolasci Chiara C CC Kidnapillai Srisaiyini S Spolding Briana B Truong Trang T T TTT Connor Timothy T Swinton Courtney C Panizzutti Bruna B Liu Zoe S J ZSJ Sanigorski Andrew A Dean Olivia M OM

Ndufs4 KO mice: A model to study comorbid mood disorders associated with mitochondrial dysfunction.

Journal: Pharmacology, biochemistry, and behavior

Publication Year: 2024

Authors & Co-authors:  van Rensburg Daniël J DJ Lindeque Zander Z Harvey Brian H BH Steyn Stephan F SF